Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

G. J. Roboz*, F. J. Giles, A. F. List, J. E. Cortes, R. Carlin, M. Kowalski, S. Bilic, E. Masson, M. Rosamilia, M. W. Schuster, D. Laurent, E. J. Feldman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences